TrialAntimicrobial agents and chemotherapy1999

Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults.

B M Sadler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.